|
|
|
|
|
by bgribble
851 days ago
|
|
> and quadrupled the survival at 36 months compared to placebo-chemotherapy There are lots of ways to slice the data. I think the one I quote is probably what got the researchers so excited. The problem is that the 36-month survival is pretty low, so even quadrupling it only increases the average survival time by the 1.6 months or whatever. Mesothelioma is one of the worst. My mom died of it at age 53, which is way too young. |
|